@article{oai:nagasaki-u.repo.nii.ac.jp:00015213,
 author = {Nanashima, Atsushi and Omagari, Katsuhisa and Sumida, Yorihisa and Abo, Takafumi and Fukuoha, Hidetoshi and Takeshita, Hiroaki and Hidaka, Shigekazu and Tanaka, Kenji and Sawai, Terumitsu and Yasutake, Toru and Nagayasu, Takeshi and Mizuta, Youhei and Ohba, Kazuo and Ohnita, Ken and Kadokawa, Yoshiko},
 issue = {93},
 journal = {Hepato-gastroenterology},
 month = {Jul},
 note = {BACKGROUND/AIMS: A new prognostic staging system, the SLiDe (S, stage; Li, liver damage; De, des-gamma-carboxy prothrombin) score was recently proposed. We examined 207 HCC patients following hepatic resection to determine the usefulness of this staging system for HCC patients after surgery. METHODOLOGY: Disease-free and overall survival rates were calculated according to the Kaplan-Meier method, and differences between groups were tested for significance using the log-rank test. RESULTS: Regarding disease-free survival, there were no significant differences in survival between SLiDe score 0 vs 1, between score 2 vs 3, and between score 4 vs 5. There were significant differences between 0-1 vs 2-3 (p < 0.01) and between 2-3 vs 4-5 (p < 0.01). Regarding overall survival, there were no significant differences in survival between score 0 vs 1, between score 2 vs 3, and between score 4 vs 5. There were significant differences between 0-1 vs 2-3 (p < 0.05) and between 2-3 vs 4-5 (p < 0.01). CONCLUSIONS: The SLiDe score, a staging system that combines tumor factors, a tumor marker and hepatic function, might be a better predictor of prognosis in HCC patients who have undergone hepatic resection., Hepato-gastroenterology, 56(93), pp.1137-1140; 2009},
 pages = {1137--1140},
 title = {Evaluation of new prognostic staging systems (SLiDe score) for hepatocellular carcinoma patients who underwent hepatectomy.},
 volume = {56},
 year = {2009}
}